Nuvation Bio Announces FDA Clearance of Investigational New DrugNUVB: Nuvation Bio Inc.
2021-12-13 07:00:00
Nuvation Bio Announces FDA Clearance of Investigational New Drug Application for NUV-422 for the Treatment of Prostate Cancer
−0.35USD
−75.80 MUSD
134.69 M
About Nuvation Bio Inc.
Sector
Industry
CEO
David T. Hung
Website
Headquarters
New York
Employees (FY)
51
Founded
2018
FIGI
BBG00VHJ0CC1
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of NUVB is 2.68 USD — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Nuvation Bio Inc. stocks are traded under the ticker NUVB.
Nuvation Bio Inc. is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
NUVB stock is 5.28% volatile and has beta coefficient of 2.66. Check out the list of the most volatile stocks — is Nuvation Bio Inc. there?
NUVB earnings for the last quarter are −0.09 USD per share, whereas the estimation was −0.11 USD resulting in a 14.29% surprise. The estimated earnings for the next quarter are −0.10 USD per share. See more details about Nuvation Bio Inc. earnings.
Yes, you can track Nuvation Bio Inc. financials in yearly and quarterly reports right on TradingView.
NUVB stock has fallen by 5.63% compared to the previous week, the month change is a 18.58% rise, over the last year Nuvation Bio Inc. has showed a 47.25% increase.
NUVB net income for the last quarter is −13.79 M USD, while the quarter before that showed −19.65 M USD of net income which accounts for 29.83% change. Track more Nuvation Bio Inc. financial stats to get the full picture.
Today Nuvation Bio Inc. has the market capitalization of 587.04 M, it has decreased by 12.36% over the last week.
No, NUVB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NUVB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuvation Bio Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 51.00 employees. See our rating of the largest employees — is Nuvation Bio Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuvation Bio Inc. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuvation Bio Inc. stock shows the neutral signal. See more of Nuvation Bio Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Nuvation Bio Inc. future price: according to them, NUVB price has a max estimate of 10.00 USD and a min estimate of 5.00 USD. Read a more detailed Nuvation Bio Inc. forecast: see what analysts think of Nuvation Bio Inc. and suggest that you do with its stocks.